Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial.
Diabetes, obesity & metabolism（2023）
摘要
Cetagliptin monotherapy was effective and well tolerated in Chinese patients with T2D who had inadequate glycaemic control on exercise and diet.
更多查看译文
关键词
cetagliptin, dipeptidyl peptidase-4 inhibitor, DPP-4, type 2 diabetes, T2D
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要